ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody.

Ying Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.